title: Level of fatigue in women receiving dose-dense versus standard chemotherapy for breast cancer: a pilot study.
abstract: OBJECTIVE
  To determine whether women receiving dose-dense chemotherapy for breast cancer experience different levels of fatigue than women receiving standard chemotherapy regimens for the disease.
  
  
  METHODS
  Quasi-experimental pilot study.
  
  
  METHODS
  Private physicians' offices in California.
  
  
  METHODS
  15 women with stage I, II, or III breast cancer receiving dose-dense or standard chemotherapy. The average female participant was 48 years old (mean = 48.3), was married (80%), and had a college degree (73%).
  
  
  METHODS
  The revised Piper Fatigue Scale was completed by patients at three different times: pretreatment, three days after their cycle 1 chemotherapy dose, and three days after their cycle 2 chemotherapy dose. Patients returned completed surveys by mail.
  
  
  METHODS
  Fatigue levels associated with chemotherapy.
  
  
  RESULTS
  Pretreatment total fatigue scores were not significantly different in the dose-dense and standard chemotherapy groups. Total fatigue scores were significantly higher in the dose-dense group at the cycle 1 and 2 time points. Fatigue scores were significantly higher in women who had undergone a mastectomy, were working, were HER2 positive, and had a tumor size larger than 2 cm.
  
  
  CONCLUSIONS
  Dose-dense chemotherapy resulted in significantly greater fatigue.
  
  
  CONCLUSIONS
  Nurses should educate women receiving dose-dense chemotherapy as part of informed consent and assist them in preparing and planning for fatigue. Information about which patients are more likely to experience significant fatigue allows nurses to judge the frequency with which they need to assess and manage fatigue to improve patient outcomes.
authors.affiliation: Southbay Oncology Hematology Partners, Campbell, CA, USA. wbbsura@yahoo.com
authors.forename: Wendy
authors.initials: W
authors.lastname: Sura
authors.forename: Susan O
authors.initials: SO
authors.lastname: Murphy
authors.forename: Irene
authors.initials: I
authors.lastname: Gonzales
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000451:nursing; D003430:Cross-Sectional Studies; D004305:Dose-Response Relationship, Drug; D005221:Fatigue / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010353:Patient Education as Topic; D011379:Prognosis